Literature DB >> 26244102

Ciprofloxacin-Loaded Keratin Hydrogels Prevent Pseudomonas aeruginosa Infection and Support Healing in a Porcine Full-Thickness Excisional Wound.

Daniel C Roy1, Seth Tomblyn2, David M Burmeister3, Nicole L Wrice3, Sandra C Becerra3, Luke R Burnett2, Justin M Saul4, Robert J Christy3.   

Abstract

Objective: Cutaneous wound infection can lead to impaired healing, multiple surgical procedures, and increased hospitalization time. We tested the effectiveness of keratin-based hydrogels (termed "keratose") loaded with ciprofloxacin to inhibit infection and support healing when topically administered to porcine excision wounds infected with Pseudomonas aeruginosa. Approach: Using a porcine excisional wound model, 10 mm full-thickness wounds were inoculated with 106 colony-forming units of P. aeruginosa and treated on days 1 and 3 postinoculation with ciprofloxacin-loaded keratose hydrogels. Bacteria enumeration and wound healing were assessed on days 3, 7, and 11 postinjury.
Results: Ciprofloxacin-loaded keratose hydrogels reduced the amount of P. aeruginosa in the wound bed by 99.9% compared with untreated wounds on days 3, 7, and 11 postinjury. Ciprofloxacin-loaded keratose hydrogels displayed decreased wound contraction and reepithelialization at day 7 postinjury. By day 11, wounds treated with ciprofloxacin-keratose hydrogels contained collagen-rich granulation tissue and myofibroblasts. Wounds treated with ciprofloxacin-loaded keratose hydrogels exhibited a transient increase in macrophages in the wound bed at day 7 postinjury that subsided by day 11. Innovation: Current therapies for wound infection include systemic antibiotics, which could lead to antibiotic resistance, and topical antimicrobial treatments, which require multiple applications and can delay healing. Here, we show that ciprofloxacin-loaded keratose hydrogels inhibit cutaneous wound infection without interfering with key aspects of the healing process including granulation tissue deposition and remodeling. Conclusions: Ciprofloxacin-loaded keratose hydrogels have the potential to serve as a point-of-injury antibiotic therapy that prevents infection and supports healing following cutaneous injury.

Entities:  

Year:  2015        PMID: 26244102      PMCID: PMC4505758          DOI: 10.1089/wound.2014.0576

Source DB:  PubMed          Journal:  Adv Wound Care (New Rochelle)        ISSN: 2162-1918            Impact factor:   4.730


  52 in total

Review 1.  Cutaneous wound healing.

Authors:  A J Singer; R A Clark
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 2.  The 10(5) bacterial growth guideline: reassessing its clinical relevance in wound healing.

Authors:  Philip G Bowler
Journal:  Ostomy Wound Manage       Date:  2003-01       Impact factor: 2.629

3.  Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds.

Authors:  Ge Zhao; Phillip C Hochwalt; Marcia L Usui; Robert A Underwood; Pradeep K Singh; Garth A James; Philip S Stewart; Philip Fleckman; John E Olerud
Journal:  Wound Repair Regen       Date:  2010-08-19       Impact factor: 3.617

Review 4.  Wound healing: an overview.

Authors:  George Broughton; Jeffrey E Janis; Christopher E Attinger
Journal:  Plast Reconstr Surg       Date:  2006-06       Impact factor: 4.730

5.  Extracellular expression of keratinase Ker P from Pseudomonas aeruginosa in E. coli.

Authors:  Richa Sharma; Rani Gupta
Journal:  Biotechnol Lett       Date:  2010-07-31       Impact factor: 2.461

6.  Systemic antimicrobial therapy in osteomyelitis.

Authors:  Henry S Fraimow
Journal:  Semin Plast Surg       Date:  2009-05       Impact factor: 2.314

7.  The pig as a model for excisional skin wound healing: characterization of the molecular and cellular biology, and bacteriology of the healing process.

Authors:  J F Wang; M E Olson; C R Reno; J B Wright; D A Hart
Journal:  Comp Med       Date:  2001-08       Impact factor: 0.982

Review 8.  Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Michael Otto
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

9.  Gentamicin-eluting bioresorbable composite fibers for wound healing applications.

Authors:  Meital Zilberman; Esty Golerkansky; Jonathan J Elsner; Israela Berdicevsky
Journal:  J Biomed Mater Res A       Date:  2009-06       Impact factor: 4.396

10.  Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats.

Authors:  K D Schmidt; B Tümmler; U Römling
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

View more
  5 in total

1.  Ciprofloxacin-loaded calcium alginate wafers prepared by freeze-drying technique for potential healing of chronic diabetic foot ulcers.

Authors:  Asif Ahmed; Giulia Getti; Joshua Boateng
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

2.  Characterization of a Human Platelet Lysate-Loaded Keratin Hydrogel for Wound Healing Applications In Vitro.

Authors:  Kameel Zuniga; Alisa Isaac; Sean Christy; Nicole Wrice; Lauren Mangum; Shanmugasundaram Natesan; Luke Burnett; Robert Christy; Christine Kowalczewski
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

3.  The Hair Follicle: An Underutilized Source of Cells and Materials for Regenerative Medicine.

Authors:  Mehrdad T Kiani; Claire A Higgins; Benjamin D Almquist
Journal:  ACS Biomater Sci Eng       Date:  2017-03-21

4.  Evaluation of Drug Delivery and Efficacy of Ciprofloxacin-Loaded Povidone Foils and Nanofiber Mats in a Wound-Infection Model Based on Ex Vivo Human Skin.

Authors:  Fiorenza Rancan; Marco Contardi; Jana Jurisch; Ulrike Blume-Peytavi; Annika Vogt; Ilker S Bayer; Christoph Schaudinn
Journal:  Pharmaceutics       Date:  2019-10-12       Impact factor: 6.321

Review 5.  Hydrogels for Atopic Dermatitis and Wound Management: A Superior Drug Delivery Vehicle.

Authors:  Ian P Harrison; Fabrizio Spada
Journal:  Pharmaceutics       Date:  2018-06-14       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.